The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Back to Technology
Technology
October 31, 2026 at 11:02 AM
The FDA wants to pull its approval of a drug. It’s not so easy.
Ars Technica
Excerpt from Ars Technica.
